Showing results (751-760 of 842) with videos related to
Sort By:
Pageof 85
Journal of Clinical Lipidology|October 21, 2019
Comparing remnant lipoprotein cholesterol measurement methods to evaluate efficacy of ezetimibe/statin vs statin therapyPeter P Toth, Harold E Bays, W Virgil Brown, et al.Orbit (Amsterdam, Netherlands)|March 17, 2022
An age-related algorithm for management of micro-orbitism from anophthalmia: a systematic review with supplemental case reportsBrandon J De Ruiter, Robert P Lesko, M Grace Knudsen, et al.Nature Communications|December 18, 2025
Genome-scale transcriptome augmentation during Arabidopsis thaliana photomorphogenesisGeoffrey Schivre, Léa Wolff, Filippo Maria Mirasole, et al.Journal of the American Heart Association|October 30, 2018
Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab TrialsAntonio J Vallejo-Vaz, Henry N Ginsberg, Michael H Davidson, et al.Atherosclerosis|July 27, 2019
Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus controlAntonio J Vallejo-Vaz, Kausik K Ray, Henry N Ginsberg, et al.Atherosclerosis|January 20, 1995
The effects of colestipol tablets compared with colestipol granules on plasma cholesterol and other lipids in moderately hypercholesterolemic patientsW Insull, M H Davidson, D M Demke, et al.The American Journal of Cardiology|August 26, 1998
Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients. The Expanded Dose Simvastatin U.S. Study GroupE A Stein, M H Davidson, A S Dobs, et al.Proceedings of the National Academy of Sciences of the United States of America|August 17, 2011
Transphyletic conservation of developmental regulatory state in animal evolutionJosé Luis Royo, Ignacio Maeso, Manuel Irimia, et al.Journal of Clinical Lipidology|February 5, 2011
Efficacy and safety of fenofibric acid in combination with a statin in patients with mixed dyslipidemia: Pooled analysis of three phase 3, 12-week randomized, controlled studiesPeter H Jones, Michael H Davidson, Anne C Goldberg, et al.JAMA|January 26, 1999
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trialM H Davidson, J Hauptman, M DiGirolamo, et al.Pageof 85